Efficacy, Safety, and Durability of Long-Acting Cabotegravir and Rilpivirine in Adults With Human Immunodeficiency Virus Type 1 Infection: 5-Year Results From the LATTE-2 Study.
Saved in:
| Title: | Efficacy, Safety, and Durability of Long-Acting Cabotegravir and Rilpivirine in Adults With Human Immunodeficiency Virus Type 1 Infection: 5-Year Results From the LATTE-2 Study. |
|---|---|
| Authors: | Smith, Graham H R1 (AUTHOR) gsmith@mlmedical.com, Henry, W Keith2 (AUTHOR), Podzamczer, Daniel3 (AUTHOR), Masiá, Maria Del Mar4 (AUTHOR), Bettacchi, Christopher J5 (AUTHOR), Arasteh, Keikawus6 (AUTHOR), Jaeger, Hans7 (AUTHOR), Khuong-Josses, Marie-Aude8 (AUTHOR), Montes-Ramírez, Maria Luisa9 (AUTHOR), Stellbrink, Hans-Jürgen10 (AUTHOR), Yazdanpanah, Yazdan11 (AUTHOR), Richmond, Gary J12 (AUTHOR), Sutton, Kenneth C13 (AUTHOR), Zhang, Feifan14 (AUTHOR), McCoig, Cynthia C15 (AUTHOR), Clair, Marty H St16 (AUTHOR), Vandermeulen, Kati17 (AUTHOR), Solingen-Ristea, Rodica Van17 (AUTHOR), Smith, Kimberly Y18 (AUTHOR), Margolis, David A13 (AUTHOR) |
| Source: | Open Forum Infectious Diseases. Sep2021, Vol. 8 Issue 9, p1-9. 9p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
